Viewing Study NCT07037004

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:21 PM
Ignite Modification Date: 2026-05-19 @ 5:56 AM
Study NCT ID: NCT07037004
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-09-23
First Post: 2025-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery
Sponsor: City of Hope Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Clear Cell Renal Cell Carcinoma View
None Sarcomatoid Renal Cell Carcinoma View
None Stage II Renal Cell Cancer AJCC v8 View
None Stage III Renal Cell Cancer AJCC v8 View
None Stage IV Renal Cell Cancer AJCC v8 View
Keywords: